A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions - Trial NCT06266988
Access comprehensive clinical trial information for NCT06266988 through Pure Global AI's free database. This Phase 1 trial is sponsored by Viatris Inc. and is currently Not yet recruiting. The study focuses on Chronic Heart Failure. Target enrollment is 48 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Viatris Inc.
Timeline & Enrollment
Phase 1
Mar 01, 2024
Aug 01, 2024
Primary Outcome
Bioequivalence based on Cmax period (using the validated Phoenix® WinNonlin® software),Bioequivalence based on AUC period (using the validated Phoenix® WinNonlin® software)
Summary
Primary objective is to is to evaluate the bioequivalence of two formulations
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06266988
Non-Device Trial